GlobalData provides unique and market-leading data and insights into the neurology market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Digital Landscape: Multiple Sclerosis

  • $6,000
  • August 2018
The Digital Landscape Multiple Sclerosis report analyzes digital activities undertaken by Pharma in support of disease-modifying therapies for Multiple Sclerosis (MS).

Acute Ischemic Stroke: Epidemiology Forecast to 2027

  • $3,995
  • July 2018
A stroke occurs when blood to the brain is either blocked or interrupted by blood clots or ruptured blood vessels; this deprives the brain of oxygen and nutrients, ultimately leading...

Acute Ischemic Stroke: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • July 2018
Stroke is caused by the interruption of the blood supply to the brain, usually because a cerebral blood vessel ruptures and bleeds (hemorrhagic stroke) or is blocked by a clot...

PharmaFocus: Tauopathies–Global Market Analysis

  • $9,495
  • February 2017
Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no treatments approved in this therapy area and five...